英文名稱  Anti-ATG4A

中文名稱  自噬相關(guān)蛋白4A抗體

濃    度  1mg/1ml

規(guī)格  0.2ml/200μg

抗體來源  Rabbit

克隆類型  polyclonal

交叉反應  Human, Mouse, Rat, Cow, Rabbit

產(chǎn)品類型  一抗

研究領(lǐng)域  腫瘤免疫學細胞凋亡轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量  predicted molecular weight: 45kDa

性    狀  Lyophilized or Liquid

免疫原  KLH conjugated synthetic peptide derived from human ATG4A

亞    型  IgG

純化方法  affinity purified by Protein A

儲存液  0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

產(chǎn)品應用   WB=1:100-500  ELISA=1:500-1000  IP=1:20-100  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500

（石蠟切片需做抗原修復）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

保存條件  Store at -20 °C for one year.

別    名  ATG4A is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.